Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Myelogenous Leukemia AML”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00104923
What this trial is testing

Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+1 more
California Cancer Consortium 29
Large-scale testing (Phase 3)Looking for participantsNCT04293562
What this trial is testing

Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Who this might be right for
Acute Myeloid Leukemia
Children's Oncology Group 1,400
Early research (Phase 1)Ended earlyNCT02610062
What this trial is testing

Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS67E Given as Monotherapy in Subjects With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Astellas Pharma Global Development, Inc. 23
Testing effectiveness (Phase 2)Looking for participantsNCT06128070
What this trial is testing

Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndrome
City of Hope Medical Center 40
Early research (Phase 1)Study completedNCT01787474
What this trial is testing

Donor Natural Killer Cells in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Recurrent Adult Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT00027560
What this trial is testing

Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more
Memorial Sloan Kettering Cancer Center 51
Testing effectiveness (Phase 2)Study completedNCT00235560
What this trial is testing

Rapamycin in Combination With Low-dose Aracytin in Elderly Acute Myeloid Leukemia Patients

Who this might be right for
Acute Myeloid Leukemia
University Hospital, Toulouse 50
Testing effectiveness (Phase 2)Study completedNCT02842827
What this trial is testing

Bomedemstat (IMG-7289/MK-3543) With and Without ATRA, in Participants With Advanced Myeloid Malignancies (IMG-7289-CTP-101/MK-3543-001)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA) 45
Testing effectiveness (Phase 2)Study completedNCT03941769
What this trial is testing

2018-0674 - IL-7 for T-Cell Recovery Post Haplo and CB Transplant - Phase I/II

Who this might be right for
Acute Myeloid LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 PositiveCord Blood Transplant Recipient+2 more
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Ended earlyNCT01795924
What this trial is testing

Safety and Efficacy Study of PD-616 Plus Cytarabine to Treat Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndrome
Biosuccess Biotech Co., Ltd. 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT07437170
What this trial is testing

Selinexor Combined With Induction Chemotherapy for Children With NUP98-positive AML

Who this might be right for
Acute Myeloid LeukemiaPediatric Acute Myeloid LeukemiaNUP98 Fusion-positive Acute Myeloid Leukemia
The Children's Hospital of Zhejiang University School of Medicine 10
Early research (Phase 1)Ended earlyNCT02370888
What this trial is testing

Lenalidomide After Allo-Hematopoietic Cell Transplant (HCT) in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndromes (MDS) Subjects With Minimal Residual Disease

Who this might be right for
Leukemia, MyeloidMyelodysplastic Syndromes
University of Florida 11
Testing effectiveness (Phase 2)Looking for participantsNCT06221683
What this trial is testing

Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML

Who this might be right for
AML, ChildhoodAcute Myeloid Leukemia
Children's Hospital of Soochow University 500
Early research (Phase 1)Ended earlyNCT04937166
What this trial is testing

Dual-SIgnaling Protein 107 (DSP107) for Patients With Hematological Malignancies

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromesChronic Myelomonocytic Leukemia
Kahr Medical 25
Early research (Phase 1)Study completedNCT02835729
What this trial is testing

Indoximod in Combination With (7+3) Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
NewLink Genetics Corporation 54
Not applicableStudy completedNCT01229956
What this trial is testing

Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 32
Early research (Phase 1)Looking for participantsNCT02203903
What this trial is testing

Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies

Who this might be right for
Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS
Catherine Bollard 50
Early research (Phase 1)WithdrawnNCT02826642
What this trial is testing

A Dose Finding Study of IDH305 With Standard of Care in IDH1 Mutant Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT00952588
What this trial is testing

Study to Investigate the Efficacy, Safety and Tolerability of AZD1152 Alone and in Combination With Low Dose Cytosine Arabinoside (LDAC)in Acute Myeloid Leukaemia (AML) Patients

Who this might be right for
Acute Myeloid Leukemia
AstraZeneca 74
Testing effectiveness (Phase 2)Study completedNCT00954941
What this trial is testing

Ondansetron Versus Aprepitant Plus Ondansetron for Emesis

Who this might be right for
Hematologic DiseasesAcute Myelogenous LeukemiaMyelodysplastic Syndrome+1 more
M.D. Anderson Cancer Center 100
Next Page